30
Sep
Centaur Pharmaceuticals launched a New Chemical Entity (NCE) – WOXheal. With its dual mechanism of action, WOXheal is a unique product in the treatment of Diabetic Foot ulcers. Amongst other complications of Diabetes, Diabetic foot ulcer is the most common complication seen in India. Apart from the fact that diabetic foot ulcers are non-healing, they not only hamper the Quality of life of the patient, but may also lead to many complications, all leading to a total or partial foot amputation. Mr. S. D. Sawant, Chairman and MD of Centaur Pharmaceuticals, said, “We, at Centaur Pharmaceuticals, were deeply concerned with…